The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Chlormethine gel for mycosis fungoides
Chalid Assaf, MD, PhD, Helios Klinikum Krefeld, Krefeld, Germany, talks on the use of topical chlormethine gel in the treatment of cutaneous T-cell lymphoma (CTCL), highlighting it’s role in the treatment of mycosis fungoides as a monotherapy in early stages, and in combination with systemic drugs. Dr Assaf also gives an overview of the safety profile of chlormethine gel and discusses how side effects can be reduced. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
